Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A global phase 3 clinical study of DFP-10917

Trial Profile

A global phase 3 clinical study of DFP-10917

Phase of Trial: Phase III

Latest Information Update: 31 May 2017

At a glance

  • Drugs DFP 10917 (Primary)
  • Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2017 New trial record
    • 24 Mar 2017 As per Nippon Shinyaku media release, this trial is planned to initiate in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top